Literature DB >> 33386912

The pre-operative and post-operative imaging appearances of urethral strictures and surgical techniques.

Jamey L Sheehan1, Haresh V Naringrekar1, Anne Kathryn Misiura1, Sandeep P Deshmukh1, Christopher G Roth2.   

Abstract

Urethral strictures arise from a variety of etiologies, most commonly either iatrogenic or inflammatory in the anterior urethra and iatrogenic/surgical or traumatic etiologies in the posterior urethra. Diagnosis and treatment planning depend on urethrography, usually performed with a combination of retrograde urethrography (RUG) and voiding cystourethrography (VCUG) to evaluate the anterior and posterior urethra, respectively. While this is most commonly performed fluoroscopically, sonographic urethrography is an alternative, although at the expense of the posterior urethra, it is only visualized using a transrectal approach. In addition to understand urethral anatomy, familiarity with normal periurethral structures is necessary to avoid misdiagnosis, such as Cowper's ducts, the glands of Littré, and the prostatic and ejaculatory ducts. Surgical management depends on the stricture location, length, and number and options range from balloon dilatation to endoscopic urethrotomy to anastomotic and substitution urethrotomy. Postprocedural management includes urethrography to identify potential complications including urethral leak, graft failure, and stricture recurrence.

Entities:  

Keywords:  Stricture; Urethra; Urethrography; Urethroplasty

Year:  2021        PMID: 33386912     DOI: 10.1007/s00261-020-02879-8

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  1 in total

1.  Retrograde urethrography, sonouretrography and magnetic resonance urethrography in evaluation of male urethral strictures. Should the novel methods become the new standard in radiological diagnosis of urethral stricture disease?

Authors:  Frankiewicz Mikolaj; Markiet Karolina; Kozak Oliwia; Krukowski Jakub; Kałużny Adam; Belka Mariusz; Naumczyk Patrycja; Matuszewski Marcin
Journal:  Int Urol Nephrol       Date:  2021-10-02       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.